Skip to main content
Premium Trial:

Request an Annual Quote

BioSource Regains Nasdaq Compliance, Will Resume Trading July 5

NEW YORK, June 30 (GenomeWeb News) - BioSource International has regained compliance with the Nasdaq and will resume trading on the exchange July 5, the company said today.

 

As GenomeWeb News reported, BioSource  received  a notice from the exchange in May indicating that the company was not in compliance with its requirements for continued listing because it failed to file a first-quarter financial report in a timely manner.

 

The company said at the time that the notice indicated its stock would be delisted if a financial report were not filed by July 3. BioSource filed its first-quarter return on June 28 and has received notification from the Nasdaq Office of General Counsel, Listing Qualifications Hearings "confirming compliance with SEC filing requirements and all other requirements for continued listing on the Nasdaq National Market."

 

The stock had been trading under the amended symbol "BIOIE" since May 27 after BioSource received the delisting notice.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.